Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Enalapril recalled?

Yes — there is an active recall. 5 ongoing FDA recalls mention Enalapril (22 total). Check the affected lots below.

Most common reason: Impurity / degradation (11 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Enalapril. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Enalapril recalls in 2026

1 initiated in 2026, 22 in total — newest first
Class II · Moderate risk

Enalapril Maleate Tablets

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Ongoing Impurity / degradation JB Chemicals and Pharmaceuticals Ltd NDC 64980-688-10 D-0520-2026
Class III · Low risk

Enalapril Maleate

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC D-0992-2018
Class III · Low risk

Enalapril Maleate

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC D-0991-2018
Class III · Low risk

Enalapril Maleate

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC D-0990-2018
Class III · Low risk

Enalapril Maleate Tablets

Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Terminated Impurity / degradation Major Pharmaceuticals NDC 0904-5502-61 D-0980-2018
Class III · Low risk

Enalapril Maleate Tablets

Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Terminated Impurity / degradation Major Pharmaceuticals NDC 0904-5609-61 D-0979-2018
Class III · Low risk

Enalapril Maleate Tablets USP

Failed Impurities/Degradation Specification; out-of-specification results for the Enalapril DKT degradant

Terminated Impurity / degradation American Health Packaging NDC 68084-390-01 D-0915-2018
Class III · Low risk

ENALAPRIL MALEATE Tablets

Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC NDC 33261-0693-90 D-0053-2018
Class III · Low risk

Enalapril Maleate tablets

Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.

Terminated Impurity / degradation Wockhardt Usa Inc. D-0051-2018
Class II · Moderate risk

Enalapril Maleate active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-648-2015
Class III · Low risk

Vasotec (enalapril maleate)

Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.

Terminated Labeling / mix-up Valeant Pharmaceuticals North America LLC NDC 0187-0140-90 D-0019-2015
Class III · Low risk

Enalapril Maleate Tablet

Labeling Illegible: Some bottles labels have incomplete NDC numbers and missing strength.

Terminated Labeling / mix-up Apace KY LLC NDC 15338-211-30 D-1683-2012